SENNA TIME
- Manufacturer
- NCS HealthCare of KY, LLC dba Vangard Labs
- Effective date
- 2024-07-25
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 11
- Source
- full-release
- Hydrated at
- 2026-06-01 00:17:31
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Sennosides 8.6 mg
OTC - PURPOSE SECTION
Purpose
Laxative
INDICATIONS & USAGE SECTION
Uses
- relieves occasional constipation (irregularity)
- generally causes bowel movement in 6-12 hours
WARNINGS SECTION
Warnings
Do not use
- laxative products for longer than 1 week unless directed by a doctor
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel movements that continues over a period of 2 weeks
OTC - STOP USE SECTION
Stop use and ask a doctor if
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- take preferably at bedtime or as directed by a doctor
- if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease dose until you are comfortable
age | Starting dosage | Maximum dosage |
| adults and children 12 years and over | 2 tablets once a day | 4 tablets twice a day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
SPL UNCLASSIFIED SECTION
Other information
- each tablet contains: calcium 25 mg, sodium 2 mg (VERY LOW SODIUM)
- store at 25°C (77°F) excursions permitted between 15°-30°C (59°-86°F)
INACTIVE INGREDIENT SECTION
Inactive ingredients croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil
OTC - QUESTIONS SECTION
Questions or comments: call 1-877-290-4008
SPL UNCLASSIFIED SECTION
191R 1121
Manufactured by: Time-Cap Labs, Inc.
7 Michael Avenue, Farmingdale, NY 11735
Principal Display Panel
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 763296 | Senna-Time 8.6 MG Oral Tablet | PSN | 11 |
| 312935 | sennosides 8.6 MG Oral Tablet | PSN | 11 |
| 763296 | sennosides, USP 8.6 MG Oral Tablet [Senna-Time] | SBD | 11 |
| 312935 | sennosides, USP 8.6 MG Oral Tablet | SCD | 11 |
| 763296 | Senna-Time 8.6 MG Oral Tablet | SY | 11 |
| 312935 | sennosides A and B 8.6 MG Oral Tablet | SY | 11 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0615-8402-05 | SENNA TIME | 15 in 1 BLISTER PACK | TABLET, COATED | 15 | 11 | |
| 0615-8402-39 | SENNA TIME | 30 in 1 BLISTER PACK | TABLET, COATED | 30 | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49483-080-01 | EA - Each | 49483-080 | 2a975f41-459c-40f7-bd31-b959b44eb14d | 1 | 2012-07-24 |
| 49483-080-10 | EA - Each | 49483-080 | 13d69fcc-a762-4953-9a30-e27716d917a0 | 1 | 2012-07-24 |
Products#
Every source-derived product name is available through these pages.
- SENNA TIME
- SENNOSIDES
- SENNOSIDES A AND B
- CROSCARMELLOSE SODIUM
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE
- HYPROMELLOSES
- MAGNESIUM STEARATE
- MICROCRYSTALLINE CELLULOSE
- MINERAL OIL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0615-8402 | 0615-8402-39, 0615-8402-05 |
| 49483-080 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SENNOSIDES A AND B | 1B5FPI42EN | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SENNA TIME | SENNOSIDES | TIME CAP LABORATORIES, INC | 18ec8127-422c-4c1a-8331-58dabce69969 | 2025-02-08 | Warnings | 49483-080 |
| SENNA TIME | SENNOSIDES | NCS HealthCare of KY, LLC dba Vangard Labs | c1aa28e7-2c7e-4fbd-842d-11082fbcbfe6 | 2024-07-25 | Warnings | 0615-8402-05 0615-8402-39 0615-8402 00615840239 00615840205 fda7565f-7224-46a0-b3cc-d3b9d4fbb373 c1aa28e7-2c7e-4fbd-842d-11082fbcbfe6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
